ABSTRACT: The success of cancer treatment depends on the response to chemotherapeutic agents. However, malignancies often acquire resistance to drugs if they are used frequently. Combination therapy involving both a chemotherapeutic agent and molecularly targeted therapy may have the ability to retain and enhance therapeutic efficacy. Here, we addressed this issue by examining the efficacy of a novel therapeutic strategy that combines AICAR and DOX within a multifunctional platform. In this context, we reported the bottom-up synthesis of Fe 3 O 4 @SiO 2 (FITC)-FA/AICAR/ DOX multifunctional nanoparticles aiming to neutralize survivin (BIRC5) to potentiate the efficacy of DOX against chemoresistance. The structure of nanoparticles was characterized by dynamic light scattering (DLS), zeta-potential measurement, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), and electron microscopy (SEM and STEM with EDX) techniques. Cellular uptake and cytotoxicity experiments demonstrated preferentially targeted delivery of nanoparticles and an efficient reduction of cancer cell viability in five different tumor-derived cell lines (A549, HCT-116, HeLa, Jurkat, and MIA PaCa-2). These results indicate that the multifunctional nanoparticle system possesses high inhibitory drug association and sustained cytotoxic effect with good biocompatibility. This novel approach which combines AICAR and DOX within a single platform might be promising as an antitumor treatment for cancer.
■ INTRODUCTION
Chemotherapy is one of the principal modes of treatment for cancer, but the effectiveness of chemotherapy is limited by drug resistance. 1 Chemotherapeutic agents are generally used in combination with a maximum tolerated dose to eliminate drug resistance and then to achieve maximum cancer cell killing. 2 However, most patients do not respond to these drugs and they often experience severe adverse effects because of greater toxicity compared to each drug alone. 3 One of the major factors responsible for chemoresistance is the evolution of the tumor cells toward a phenotype that is resistant to apoptotic cell kill. On a molecular level, increased expression of the inhibitor of apoptosis protein family (IAPs) has been detected in this phenotype. 4 Therefore, interfering with IAPs expression or function is a new strategy to eliminate drug resistance. Survivin, a structurally unique member of the IAP family that acts as a suppressor of apoptosis and plays a central role in cell division, is overexpressed in all human cancers, but demonstrates low expression in normal tissues. 5 Several preclinical studies in different human tumor models have demonstrated that downregulation of survivin expression or function, accomplished by means of various strategies, reduced tumor growth potential, increased the apoptotic rate, and sensitized tumor cells to chemotherapeutic drugs. 6 Heat shock protein 90 (Hsp90) is a significant target in the development of rational cancer therapy due to its role at the crossroads of multiple signaling pathways associated with cell proliferation and cell viability. Through combined structure-and dynamicsbased computational design strategy and experimental tests, Meli et al. reported that the nonpeptidic small molecule 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) binds the Hsp90 N-domain, destabilizes multiple Hsp90 client proteins in vivo, including survivin, and exhibits antiproliferative and proapoptotic activity in multiple tumor cell lines, while not affecting proliferation of normal human fibroblasts. 7 Doxorubicin (DOX) is a common chemotherapeutic used in the treatment of a wide range of cancers because of its excellent antitumor activity. 8 Resistance to this agent impairs treatment of cancer patients and prevents successful treatment. 9 In addition, DOX has a relatively low therapeutic index and its clinical usage is limited due to acute and chronic toxicities such as immunosuppression and cardiotoxicity. 10 Therefore, more efficient treatment strategies must be developed that reduce or eliminate drug resistance, decrease the cytotoxic effects of DOX, and also enhance therapeutic efficacy. Considering the potential value of reducing or abolishing survivin expression as a means of overcoming chemoresistance, we have successfully developed a core/shell type of nanoparticle formulation to codeliver AICAR and DOX, thereby enhancing antitumor activity while reducing chemoresistance.
In recent years, multifunctional particles with magnetism, fluorescence, and target navigation have been explored extensively in biomedical applications. They have been developed as an all-in-one biomedical platform for simultaneous fluorescence imaging, manipulation of cells, and drug delivery tools. 11−14 Among the various multifunctional particles, dye-doped silica magnetic-fluorescent composites are very promising biomedical materials due to the following advantages: (1) their high photostability and relatively strong fluorescent signal owing to their high dye-incorporation capabilities and stabilization in a protective silica matrix with biocompatibility and less toxicity; (2) superparamagnetic oxide iron nanoparticles with fast magnetic response making it easy to manipulate via an external magnetic field, and this "remote control" providing considerable advantages for many applications; 15 (3) contrast agents with both optical and magnetic contrast serving as good molecular imaging probes both in vitro and in vivo. 16 In addition, active targeting of nanoparticles can potentially increase the efficacy and reduce the toxicity of therapeutic agents. 17 This is achieved by conjugating the surface of nanoparticles using specific cell ligands. Folic acid (FA) has been widely used in the delivery of anticancer agents due to its small size, low cost, high tumor tissue specificity, nonimmunogenic nature, and fast internalization through the cellular membrane. 18 FA linked nanocarriers have fairly high binding affinity to folate receptors (FR) expressed on tumor cells. 19 In this study we have rationally designed the bottom-up synthesis of four successive nanoparticles: (1) @SiO 2 (FITC)-FA/AICAR/DOX nanoparticles containing both inhibitor and drug to evaluate synergistic potential of therapeutics. The feasibility of nanoparticles was evaluated by investigating their capability in cellular uptake, fluorescent imaging, and cytotoxic effect in five different tumor-derived cell lines (A549, HCT-116, HeLa, Jurkat, and MIA PaCa-2). To the best of our knowledge, this is the first study which combines AICAR and DOX as therapeutic agents and examines their synergetic effect within a multifunctional platform. The preliminary cell tests confirm the potential of these multifunctional nanoparticles as an antitumor treatment in cancer therapy. 
■ RESULTS AND DISCUSSION
Synthesis and Characterization of Multifunctional Nanoparticles. To construct the nanoparticles, silica (SiO 2 ) was used for surface coating of F 3 O 4 particles because dye molecules can be easily incorporated into a silica shell, and silica is quite biocompatible and resistant to biodegradation in biological environments. 24 In addition, silica can be easily surface functionalized for bioconjugation and targeted for various applications in biological systems. Hence, in this study we first synthesized bifunctional nanoparticles, F 3 O 4 @ SiO 2 (FITC) (Figure 1 ) with both fluorescent and magnetic properties by sol−gel formation of the silica layer onto the magnetite surface. To increase the cellular uptake of magnetic iron oxide particles, nanoparticles were vectorized with folic acid by silanization FA-APTES conjugate on the silica surface and simultaneously the surfaces were modified with free APTES to form an amine-terminated overlayer for the subsequent conjugation of both AICAR and DOX via Schiff-base formation. In general, two different approaches have been explored for drug transportation by nanoparticles. The first consists of conjugating the drugs covalently to the nanoparticle surface through appropriate linkers, and the second in physically adsorbing or establishing ionic and hydrogen bonds. The covalent method is the most used because the bond strength makes nanoparticle−drug conjugates highly stable. 25 Thus, after surface modification with APTES, AICAR and DOX were covalently linked on the surface of nanoparticles from their amine group using glutaraldehyde as a linker. In this step, different concentrations of glutaraldehyde were tested separately to determine the optimal linker concentration ( Table 1) . Among the tested amounts of glutaraldehyde, the highest coupling yield of AICAR and DOX complexes was observed at 1% glutaraldehyde concentration. The amount of bound AICAR or DOX was calculated from the difference between the amount of AICAR or DOX introduced into the coupling reaction mixture and the amount of AICAR or DOX present in the washing water after immobilization by measuring AICAR or DOX absorbance at 260 and 480 nm, respectively.
The average hydrodynamic diameter of the oleic acid stabilized Fe 3 O 4 nanoparticles, determined for 0.1/0.2/0.4/0.6 mL concentrations of oleic acid by DLS, were 4.9 ± 1.2, 7.8 ± 1.5, 12.1 ± 3.8, and 18.7 ± 7 nm, respectively. Since oleic acid effectively regulates Fe 3 O 4 nanoparticle growth and prevents aggregation, different amounts of oleic acid were tested to produce size-controlled monodisperse Fe 3 O 4 nanoparticles. The nanoparticle sizes increased regularly with increasing amount of oleic acid, due to increased chemisorption of oleate ions on the magnetite particles. Therefore, we chose the nanoparticles stabilized with 0.1 mL oleic acid in the next study to obtain the proper nanoparticles with narrow size distribution. The silica coating led to an increase of the average particle size (∼17 nm) ( Table 2 ). After the immobilization process, the size of nanoparticles attached with both AICAR and DOX increased to approximately 79 nm. Particles with a diameter ranging from 10 to 100 nm are optimal for intravenous injection and have the most prolonged blood circulation times. These particles are small enough to evade the Reticuloendothelial System (RES) of the body as well as to penetrate small capillaries of the tissues and offer the most effective distribution in targeted tissues. 26 The zeta potential of nanoparticles was analyzed to confirm the change in their surface potential due to proper biofunctionalization. The stepwise conjugation of functional groups on the silica surface was monitored by measuring the surface charges at different stages of synthesis ( Figure 2 and Table 2 ). A negative zeta potential (ζ) value of −17.5 mV (pH 7.4) of Fe 3 O 4 @SiO 2 (FITC) nanoparticles can be attributed to the presence of ionizable silanol groups of silica surface. After modification with APTES/FA conjugate, the zeta potential value of Fe 3 O 4 @SiO 2 (FITC)-FA/NH 2 nanoparticles reverted to a positive value (+5.3 mV at pH = 7.4) due to the presence of an excess of positively charged amino groups. FA is expected to furnish silica surface with negative charge; however, the excess amount of NH 2 groups presumably nullify the FA charge and make the overall surface charge slightly positive. Further modification of the surface by conjugating both AICAR or DOX groups reverted the surface charge back to a negative value, for The bulk crystal structure of the nanoparticles was analyzed by X-ray diffraction (XRD) using the Debye−Scherrer method. This result indicated that the silica coating did not cause a phase change in the magnetic particles. Therefore, the magnetic particles could preserve their magnetic properties for further applications. Simultaneously, the characteristic peak at 2θ of 18.1°was observed for the fluorescent FITC, which exists in the silica layer in samples. 28 The surface modification and conjugation of nanoparticles with APTES, FA, AICAR, and DOX were confirmed by Fourier transform infrared (FTIR) spectroscopy. For comparison, in oleic acid, confirm the presence of the oleic acid on the Fe 3 O 4 surface. 29 The spectrum of Fe 3 O 4 nanoparticles exhibited a strong peak at 584 cm −1 which is assigned to typical Fe−O vibrations of the magnetite structure, sustaining the iron oxide identification by XRD. 30 In the FTIR spectra of , and Si−O−Si bending vibrations at 467 cm −1 were observed, thus confirming the formation of the silica shells. 31 The broad band around 3425 cm −1 was due to O−H stretching vibrations of adsorbed water and hydrogen-bonded surface silanol groups, whereas the bands around 1548 and 1632 cm −1 are attributed to bending of N−H, characteristic of the presence of an NH 2 group. 32 Furthermore, a significant decrease in the intensity of the bands related to Fe−O vibrations at 580 cm −1 , revealing an increase in the thickness of the silica shells and the complete encapsulation of the magnetic cores, in accordance with the results from XRD and EDX.
The band at 1606 cm −1 corresponding to the stretching vibrations of CC in the backbone of the aromatic ring present in folic acid, indicated the immobilization of folic acid on nanoparticle surfaces. The peak at 1534 cm −1 is due to the primary amine group of APTES, indicating that the nanoparticles have been surface modified by amine group. The band at 1585 cm −1 , referred to as the stretching vibration of two carbonyl groups of the anthracene ring of DOX, 33 indicated that DOX was successfully attached to the surface of the nanoparticles. The spectral range between 1000 and 800 cm −1 is very informative on nucleic acid absorption, due to sugar vibrations sensitive to their conformation and to backbone vibrational modes. Therefore, the bands at 890 and 926 cm −1 indicated that AICAR immobilization with covalent bonding on the surface of the nanoparticles was successfully achieved. 34 The grafting density of FA, AICAR, and DOX on nanoparticles was analyzed by measuring the differences of weight loss due to organics decomposition in both The exterior morphologies and interior structures of the nanoparticles at different fabrication stage were investigated by SEM and STEM, respectively; and the related chemical compositions were determined by EDX.
SEM images showed that the parent iron oxide nanoparticles were nearly spherical and present a narrow size distribution (Figure 6a/b/c) . The corresponding EDX spectrum confirmed that the Fe 3 O 4 particles are composed of Fe and O, with the C peak indicating the presence of a thin oleic acid shell enveloping the magnetic cores, without any impurity. The untagged Al peak is from the double stick aluminum tape used in sample preparation (Figure 7a and Cytotoxicity of the Multifunctional Nanoparticles. To examine how the conjugation of AICAR with DOX affected its cytotoxicity, we compared the proliferation of A549, HCT-116, HeLa, Jurkat, and MIA PaCa-2 cells treated with the nanoparticle complexes using MTT cell proliferation assay. First, we chose a concentration of DOX (20 μM) 10 times lower than the concentration of AICAR (200 μM) during immobilization processes in terms of minimal growth inhibition in these cells for our combination therapy studies. Next, we investigated whether combination therapy with the inhibitor and drug would be effective at inhibiting tumor cell proliferation and inducing cell death. Cancer cells were exposed to nanoparticles with increasing concentrations of nanoparticles (0. that the maximum amount of these nanoparticles in the cells was not sufficient to affect cell viability. This implies that a higher concentration of the nanoparticles would be needed to obtain a notable reduction in cell viability.
As survivin is not a cell surface protein and does not have an intrinsic enzymatic activity, targeting of survivin for therapeutic purposes has been mostly employed at the transcriptional levels. 6 A number of siRNA-based therapies have been reported as survivin neutralizing agent to increase the sensitivity of cancer cells to DOX and have managed to restore sensitivity to chemotherapeutically induced apoptosis in several cancer cells. 36, 37 However, one of the main hurdles to the application of siRNA-based therapy identified to date is the potential offtarget effects. It has been well-documented that delivering siRNA into cells can suppress the expression of genes other than the desired targets. 38 To eliminate these obstacles, AICAR could be of potential value for increasing the sensitivity of cancer cells to anticancer drugs, as a small-molecule inhibitor that could be easily incorporated in practice for the downregulation of survivin.
■ CONCLUSIONS
Herein we presented successful fabrication and characterization of novel magnetic-fluorescence based, folic acid functionalized nanoparticles for simultaneous delivery of AICAR and DOX into cancer cells. These multifunctional nanoparticles were synthesized by a simple coprecipitation of Fe 2+ /Fe 3+ salts which were then encapsulated within a SiO 2 shell to provide surface modification and biocompatibility as well as to act as a host for fluorescent dye (FITC). The cancer targeting feature was endowed by conjugating FA on the surface of nanoparticles via an esterification reaction. AICAR and DOX complexes were then successfully attached on the amine-functionalized nanoparticles using Schiff-base chemistry. As far as we know, the synergetic effect of AICAR and DOX has not yet been investigated and this is the first successful preparation of AICAR-DOX conjugated luminomagnetic nanoparticles as a single platform. The structures of the newly synthesized nanoparticles have been confirmed by different characterization techniques: DLS; XRD; FTIR; TGA; EDX; SEM; and STEM. The nanoparticles possess high inhibitor and drug association with good biocompatibility. In addition, the preparation procedure is an environmentally friendly and low-cost synthetic route.
The combination of AICAR and DOX is expected to maximize tumor cell killing by sensitization of cancer cells and detectable cell numbers about 10 5 confirming cellular uptake of nanoparticles. Moreover, the nanoparticles not only served as a nanocarrier but also exhibited synergistic cytotoxic activity against the cancer cells. We have demonstrated that combination therapy with Fe 3 O 4 @SiO 2 (FITC)-FA/AICAR/ DOX nanoparticles is superior to monotherapy with nanoparticles decorated with either AICAR or DOX alone. Importantly, the combination effects of the nanoparticles were confirmed in five different cancer cell lines. Our data indicate a strong effect of Fe 3 O 4 @SiO 2 (FITC)-FA/AICAR/ DOX nanoparticles on the lung carcinoma A549 and the cervical carcinoma HeLa cell lines, while similar outcomes were observed on the colon carcinoma HCT-116, the leukemia Jurkat, and the pancreatic carcinoma MIA PaCa-2 cell lines. We believe that this combination will be a valuable addition in the sensitization of cancer cells toward anticancer drugs to improve the therapeutic outcome of chemotherapy. Finally, it could be concluded that coadministration of AICAR and DOX might promote apoptosis more than each drug alone or incubation of one compound prior to the other one. The characterization of apoptotic and antiproliferative effects and related caspase-3 activity studies of the nanoparticles are currently under investigation.
■ MATERIAL AND METHODS

Materials. Iron(II) chloride tetrahydrate (FeCl
folic acid (FA), dimethyl sulfoxide (DMSO), triton X-100, FT-IR grade potassium bromide ≥99% (KBr), Glutaraldehyde 25% aqueous solution, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside ≥98% (AICAR), and 3-[4,5-dimethyl-2-thialzolyl]-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chemicals. Oleic acid (99%), cyclohexane, 1-hexanol (>98%), ammonium hydroxide 25% aqueous solution, and toluene were purchased from Fluka/Riedel-de Haen Chemicals. Doxorubicin was obtained from SABA Pharma. DMEM growth medium, RPMI-1640 growth medium, 10% fetal bovine serum (FBS), streptomycin, penicillin, and L-glutamic acid were purchased from Gibco Life Technologies. All other chemicals and reagents were of the highest purity. All the experiments were performed in deionized Milli-Q water.
Cell Cultures. A549 (human epithelial lung carcinoma), HCT-116 (human epithelial colorectal carcinoma), HeLa (human epithelial cervical carcinoma), Jurkat (human acute T-cell leukemia), and MIA PaCa-2 (human epithelial pancreatic carcinoma) cell lines were kindly provided by Biotechnology and Bioengineering Research and Application Centre, Izmir Institute of Technology, Turkey. A549, HCT-116, HeLa, and MIA PaCa-2 cancer cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 μg/mL streptomycin, 100 U/mL penicillin, and 2 mM L-glutamic acid; Jurkat cancer cells were cultured in Roswell Park Memorial Institute-1640 (RPMI-1640) growth medium supplemented with 10% fetal bovine serum (FBS), 100 μg/mL streptomycin, 100 U/mL penicillin, and 2 mM L-glutamic acid. All cell lines were incubated in 5% CO 2 and 90−100% relative humidity at 37°C. Medium renewal was carried out 2 to 3 times per week, and cells were subcultured when they achieved 80−90% confluence. All cell lines were discarded after 20 generations, and new lines were obtained from frozen stocks.
Synthesis of Multifunctional Nanoparticles. O were dissolved in 100 mL ultrapure water under nitrogen environment with ultrasonification for 10 min. NH 4 OH (25%) aqueous solution was added dropwise until pH 10−11. After base had been added, the alkaline solution started to became dark brown. Oleic acid (0.1/0.2/0.4/0.6 mL) was added immediately to the dark brown solution and the resulting emulsion was aged, under vigorous mechanical stirring, at room temperature for 1 h. Then the emulsion was heated up to 95°C to convert iron hydroxides into magnetite. As soon as that temperature was reached, the suspension was cooled down to room temperature. The mixture was then acidified to pH 5−6 by using a HNO 3 solution (35%) to promote the chemisorption of oleate ions on the magnetite particles. Consequently, the particles coagulated and precipitated in the solution due to the hydrophobicity provided by the oleate layer. The resulting magnetic particles settled within a few minutes and were then washed with ultrapure water four times to remove the unreacted salts and with ethanol three times to remove water and nonadsorbed oleic acid. Finally, the oleic acid coated nanoparticles were dried in vacuum oven at room temperature for 12 h.
Synthesis of Fe 3 O 4 @SiO 2 (FITC) Nanoparticles. Silica core− shell nanoparticles [Fe 3 O 4 @SiO 2 (FITC)] were synthesized by a water-in-oil reverse micelle method with some modification of a published procedure in two steps. 21 In the first step, the oleic acid protected Fe 3 O 4 nanoparticles were coated with a thin silica shell by hydrolysis and condensation of TEOS as sol−gel precursor. Briefly, a microemulsion system was prepared with 10 mg of dried magnetic Fe 3 O 4 powder added to 0.3 mL TEOS, 70 mL cyclohexane, 20 g Triton X-100 (as surfactant), 15 mL n-hexanol (as cosurfactant), and 3.7 mL H 2 O mixture with intense stirring at room temperature. Six hours later, 1.0 mL aqueous NH 4 OH (25%) was introduced dropwise to initiate TEOS hydrolysis and the microemulsion was kept stirring for another 24 h. In the second step, after the first silica shell had been coated on the magnetic core, the dye molecules were encapsulated into the second silica shell to enhance photochemical stability. FITC-APTES conjugate was prepared by covalently attaching FITC to the APTES silane compound by a stable thiourea linkage. Briefly, 1.0 mg FITC and 0.15 mL APTES were combined together in 0.2 mL of absolute ethanol under nitrogen atmosphere and stirred in orbital shaker for 24 h. The FITC-APTES conjugate solution was protected from light during reaction and storage to prevent photobleaching. After 24 h, FITC-APTES ethanolic solution and 0.3 mL TEOS were added to the first microemulsion under stirring in dark for 24 h. Finally, ethanol was added to destabilize the microemulsion system. 22 First, folic acid was conjugated with APTES by an esterification reaction of the carboxyl group with the amine group. In brief, an APTES ester of FA (FA-APTES) was prepared by mixing folate (4.0 mg) with APTES (2.0 μL) in 40 mL dry dimethyl sulfoxide (DMSO) in the presence of NHS (1.1 mg) and DCC (4.7 mg) as the catalyst at room temperature for 2 h. After this, a mixture of Fe 3 O 4 @SiO 2 (FITC) nanoparticles (100 mg), FA-APTES conjugate, and free APTES (17 μL) in toluene (160 mL) was stirred at room temperature for 24 h to introduce FA-APTES conjugate and free APTES (to provide a linker for the subsequent conjugation of both AICAR and DOX) on the surface of silica-coated nanoparticles by hydrolysis and condensation of APTES through silanization. Final products were collected by a magnet, washed with toluene and ethanol several times to remove any unreacted reactants, and dried in a vacuum oven at room temperature, overnight. Structural and Physicochemical Characterization. Dynamic light scattering (DLS) measurements were performed at 25°C, using a Malvern Zetasizer NanoZS compact scattering spectrometer. The average hydrodynamic diameters, the size distributions and the surface charge analysis of the samples were determined using Malvern Dispersion Technology Software 7.11. Nanoparticles were suspended in ultrapure water (Fe 3 O 4 nanoparticles in hexane) to give optimum signal intensity. All measurements were repeated three times to verify the reproducibility of the results.
Powder X-ray diffraction (XRD) measurements were performed with "Philips X'Pert Pro", at room temperature by using Cu Kα radiation (λ = 1.5405 Å) and Bragg−Brentano θ/2θ configuration. The measurements were performed over the 2θ range of 15−70°.
The Fourier transform infrared spectroscopy (FTIR) spectra of the nanoparticles were collected with a "PerkinElmer Spectrum-100" spectrophotometer in the range 450− 4000 cm −1 . The spectra of the dried samples were obtained by employing a KBr pellet.
Thermogravimetric analysis (TGA) was performed on a PerkinElmer Diomand TG/DTA Instruments from room temperature to 650°C with a heating rate of 10°C/min in a nitrogen flow.
Scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX) studies were performed at a high resolution environmental scanning electron microscope (FEI Quanta 250 FEG) equipped with an energy-dispersive X-ray spectrometer (Oxford AZtec). Prior to examination, the lyophilized nanoparticles were placed on a double stick tape over aluminum stubs to get a uniform layer of particles.
Scanning transmission electron microscopy (STEM) images of the final nanoparticles were obtained with a "FEI Quanta 250 FEG" microscope operating with STEM Detector. The nanoparticles were dispersed in water under sonication and a drop was placed on a carbon-coated 400 mesh copper grid followed by air-drying.
Cellular Uptake Analysis. Internalization of the nanoparticles was visualized using an Olympus IX2-ILL100 fluorescence microscope equipped with an appropriate filter set. Images were acquired using a CCD camera and analyzed using ImageJ advanced version software. A549, HCT-116, HeLa, Jurkat, and MIA PaCa-2 cells (1 × 10 5 cells/well) were seeded in 12-well plates overnight before experiments. Fe 3 O 4 @ SiO 2 (FITC)-FA/AICAR/DOX nanoparticles were added into the incubation medium at concentrations of 10 μg/mL for 4 h incubation in 5% CO 2 at 37°C. All cells except Jurkat (suspension cells) and MIA PaCa-2 (suspension/adherent mixed cells) were washed twice with phosphate-buffered saline (PBS). Microscopic images in the green channel for detection of the FITC label encapsulated in nanoparticles and in the bright-field were obtained by fluorescence microscopy.
Cytotoxicity of Multifunctional Nanoparticles. The cytotoxicity of the prepared nanoparticles were evaluated by 3-(4,5-dimethylthialzol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. A549, HCT-116, HeLa, Jurkat, and MIA PaCa-2 cells were seeded into 96-well plates at a density of 1 × 10 4 per well in 100 μL of media and grown overnight. The cells were then incubated with various concentrations (0.1/1.0/ 10/50/100/200 μg/mL) of nanoparticles for 48 h at 37°C under 5% CO 2 . Following this incubation, cells were incubated in medium containing 0.5 mg/mL of MTT for 4 h. The medium was discarded, and the precipitated formazan violet crystals were dissolved in 150 μL of DMSO to solubilize the formazan. After shaking the plate for 10 min, the absorbance of the sample was measured at 570 nm by multidetection microplate reader. The absorbance of dissolved formazan in the visible region correlates with the number of intact active cells. The cytotoxicity was evaluated with reference to the IC 50 value that was defined as the concentration needed for a 50% reduction of survival based on the survival curves. IC 50 values were calculated from dose−response curves (nanoparticle concentration vs cell survival fraction) obtained in multireplicated experiments. For the combination treatment studies, the cells were incubated with (1) 
